Bronchogen

Overview

A short synthetic peptide bioregulator (Ala-Asp-Glu-Leu) from the Khavinson family, marketed for bronchial/respiratory tissue support. Evidence is largely Russian-language and preclinical.

Mechanism of Action

Proposed tissue-specific peptide-bioregulator activity in bronchial epithelium; not established by independent research.

Research Summary

Primarily Russian institutional studies; no large independent controlled human trials.

Vendors selling Bronchogen

Scored vendors carrying Bronchogen, ranked by trust grade. Grades are computed from indexed Certificates of Analysis. Full $/mg pricing is on the comparison page.

Reported Side Effects

• Not well characterized

Compare Bronchogen with Others

Frequently asked questions

Has Bronchogen been independently lab-tested?

Disclosed Labs has collected 9 Certificates of Analysis (COA) for Bronchogen from 4 independent testing labs. 4 vendors have submitted material for testing. Products average 99.5% tested purity across the corpus. Full testing data is available at https://www.disclosedlabs.com/peptides/bronchogen/testing.

What is the average purity of Bronchogen on the market?

Based on 9 COAs analyzed by Disclosed Labs, Bronchogen products average 99.5% (±0.2%) tested purity. Individual vendor results vary; see per-vendor COA data at https://www.disclosedlabs.com/peptides/bronchogen/coas.

Where can researchers source Bronchogen?

2 vendors with Disclosed Labs trust grades currently list Bronchogen, including BioLongevity Labs, Certified Peptides. Compare live prices and lab-verified COAs at https://www.disclosedlabs.com/prices/bronchogen.

How does Bronchogen work?

Proposed tissue-specific peptide-bioregulator activity in bronchial epithelium; not established by independent research.

What does the research say about Bronchogen?

Primarily Russian institutional studies; no large independent controlled human trials.